Nouveautés dans la chimiothérapie du cancer colorectal métastasé

M. Ducreux; V. Boige; N. Bouarioua; B. Leconte; H. Frikha; T. Boisserie; D. Malka

doi:10.1007/s10269-008-0851-1

Nouveautés dans la chimiothérapie du cancer colorectal métastasé

Translated title of the contribution: Developments in chemotherapy treatment of metastatic colorectal cancer

M. Ducreux, V. Boige, N. Bouarioua, B. Leconte, H. Frikha, T. Boisserie, D. Malka

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Chemotherapy of colorectal cancer has been dramatically modified during the last 10 years. Before the roles of oxaliplatin and irinotecan had been satisfactorily evaluated, targeted therapies appeared in the field of treatment for these patients. Numerous questions remain unanswered. However, recent data is helping to clarify matters concerning the day to day treatment of such patients. Clearly it is time to evaluate these recent studies and that is the aim of this article.

Translated title of the contribution	Developments in chemotherapy treatment of metastatic colorectal cancer
Original language	French
Pages (from-to)	169-174
Number of pages	6
Journal	Oncologie
Volume	10
Issue number	3
DOIs	https://doi.org/10.1007/s10269-008-0851-1
Publication status	Published - 1 Mar 2008

Access to Document

10.1007/s10269-008-0851-1

Cite this

@article{8d6383e628fe4f56b165acdb90b3b9f7,

title = "Nouveaut{\'e}s dans la chimioth{\'e}rapie du cancer colorectal m{\'e}tastas{\'e}",

abstract = "Chemotherapy of colorectal cancer has been dramatically modified during the last 10 years. Before the roles of oxaliplatin and irinotecan had been satisfactorily evaluated, targeted therapies appeared in the field of treatment for these patients. Numerous questions remain unanswered. However, recent data is helping to clarify matters concerning the day to day treatment of such patients. Clearly it is time to evaluate these recent studies and that is the aim of this article.",

keywords = "Bevacizumab, Cetuximab, Chemotherapy, Colorectal neoplasms, Irinotecan, Oxaliplatin, Panitumumab, Targeted therapies",

author = "M. Ducreux and V. Boige and N. Bouarioua and B. Leconte and H. Frikha and T. Boisserie and D. Malka",

year = "2008",

month = mar,

day = "1",

doi = "10.1007/s10269-008-0851-1",

language = "Fran{\c c}ais",

volume = "10",

pages = "169--174",

journal = "Oncologie",

issn = "1292-3818",

number = "3",

}

TY - JOUR

T1 - Nouveautés dans la chimiothérapie du cancer colorectal métastasé

AU - Ducreux, M.

AU - Boige, V.

AU - Bouarioua, N.

AU - Leconte, B.

AU - Frikha, H.

AU - Boisserie, T.

AU - Malka, D.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Chemotherapy of colorectal cancer has been dramatically modified during the last 10 years. Before the roles of oxaliplatin and irinotecan had been satisfactorily evaluated, targeted therapies appeared in the field of treatment for these patients. Numerous questions remain unanswered. However, recent data is helping to clarify matters concerning the day to day treatment of such patients. Clearly it is time to evaluate these recent studies and that is the aim of this article.

AB - Chemotherapy of colorectal cancer has been dramatically modified during the last 10 years. Before the roles of oxaliplatin and irinotecan had been satisfactorily evaluated, targeted therapies appeared in the field of treatment for these patients. Numerous questions remain unanswered. However, recent data is helping to clarify matters concerning the day to day treatment of such patients. Clearly it is time to evaluate these recent studies and that is the aim of this article.

KW - Bevacizumab

KW - Cetuximab

KW - Chemotherapy

KW - Colorectal neoplasms

KW - Irinotecan

KW - Oxaliplatin

KW - Panitumumab

KW - Targeted therapies

UR - http://www.scopus.com/inward/record.url?scp=45749128252&partnerID=8YFLogxK

U2 - 10.1007/s10269-008-0851-1

DO - 10.1007/s10269-008-0851-1

M3 - Article

AN - SCOPUS:45749128252

SN - 1292-3818

VL - 10

SP - 169

EP - 174

JO - Oncologie

JF - Oncologie

IS - 3

ER -

Nouveautés dans la chimiothérapie du cancer colorectal métastasé

Abstract

Access to Document

Other files and links

Cite this